IN8bio Presents Gamma-Delta T Cells as Cancer Therapeutics at the ESMO Targeted Anticancer Therapies Virtual Conference 2021

NEXT STORY
Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
PREV STORY
G1 Therapeutics and Boehringer Ingelheim Announce Commercial Availability of COSELA™ (trilaciclib), the Only FDA-Approved Multilineage Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced Myelosuppression
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genmab Announces European Marketing Authorization for DARZALEX® (daratumumab) for Front Line Multiple Myeloma

Company Announcement DARZALEX approved in Europe in combination with bortezomib, melphalan and prednisone in ...

author_avatar
NASDAQ Market News

Axiom celebrates 20 Years of Innovation successfully delivering hundreds of clinical trials with Fusion eClinical Suite

author_avatar
NASDAQ Market News

Onsite Partners, Inc. Adds Philip J. Stone to Executive Team

author_avatar
NASDAQ Market News